J Rhinol.  2023 Mar;30(1):53-56. 10.18787/jr.2023.00011.

A Case of Postoperative Guillain-Barré Syndrome After Nasal Surgery

Affiliations
  • 1Department of Otolaryngology-Head and Neck Surgery, Dong-A University College of Medicine, Busan, Republic of Korea

Abstract

Guillain-Barré syndrome (GBS) is an autoimmune disease that is generally preceded by an infection. Its typical symptoms are progressive symmetric paresis and an absence of deep tendon reflexes. GBS could be a life-threatening condition due to the paralysis of respiratory muscles, and admission to the intensive care unit should be considered for close monitoring. Intravenous immunoglobulin can improve the course of the disease. Postoperative GBS is most likely to occur after gastrointestinal, cardiac, thoracic, neurological, or orthopedic surgery, as well as surgery in the female reproductive tract. The duration of surgery, age, infectious diseases, preexisting autoimmune diseases, and malignant diseases are associated with postoperative GBS. Patients with these factors have a higher risk of postoperative GBS and therefore require precautions to be taken after surgery. We report a case of 53-year-old woman who had experienced GBS after Nasal surgery preceded by gastrointestinal infection and treated by intravenous immunoglobulin.

Keyword

Nasal surgery; Transanal endoscopic surgery; Guillain-Barré syndrome; Postoperative complications; Lower extremity paresis

Figure

  • Fig. 1. Preoperative magnetic resonance imaging findings. A: T1 axial view: a low-signal cystic lesion with a fluid-fluid level (red arrowheads) in the left maxillary sinus. B: T2 axial view: a high-signal cystic lesion with a fluid-fluid level (red arrowheads) in the left maxillary sinus. C: T1 gadolinium-enhanced axial view: a cystic lesion with rim enhancement (white arrow).

  • Fig. 2. Preoperative computed tomography: a 4.2×3.8 cm hypodense homogenous cystic mass in the left maxillary sinus with bone thinning of the left maxillary sinus wall.


Reference

References

1. van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014; 10(8):469–82.
Article
2. Nagarajan E, Rubin M, Wijdicks EF, Hocker SE. Guillain-Barré syndrome after surgical procedures: predisposing factors and outcome. Neurol Clin Pract. 2016 Nov 23 [Epub]. Available from https://doi.org/10.1212/CPJ.0000000000000329.
Article
3. Hocker S, Nagarajan E, Rubin M, Wijdicks EFM. Clinical factors associated with Guillain-Barré syndrome following surgery. Neurol Clin Pract. 2018; 8(3):201–6.
Article
4. Kimachi T, Yuki N, Kokubun N, Yamaguchi S, Wakerley BR. Paraparetic Guillain-Barré syndrome: nondemyelinating reversible conduction failure restricted to the lower limbs. Muscle Nerve. 2017; 55(2):281–5.
Article
5. Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain. 2014; 137(Pt 1):33–43.
Article
6. Kim JK, Bae JS, Kim DS, Kusunoki S, Kim JE, Kim JS, et al. Prevalence of anti-ganglioside antibodies and their clinical correlates with Guillain-Barré syndrome in Korea: a nationwide multicenter study. J Clin Neurol. 2014; 10(2):94–100.
Article
7. Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barré syndrome. Lancet. 2016; 388(10045):717–27.
Article
8. Yuki N, Hartung HP. Guillain-Barré syndrome. N Engl J Med. 2012; 366(24):2294–304.
Article
9. Gensicke H, Datta AN, Dill P, Schindler C, Fischer D. Increased incidence of Guillain-Barré syndrome after surgery. Eur J Neurol. 2012; 19(9):1239–44.
Article
10. Arnason BG, Asbury AK. Idiopathic polyneuritis after surgery. Arch Neurol. 1968; 18(5):500–7.
Article
11. Staff NP, Engelstad J, Klein CJ, Amrami KK, Spinner RJ, Dyck PJ, et al. Post-surgical inflammatory neuropathy. Brain. 2010; 133(10):2866–80.
Article
12. Hogan BV, Peter MB, Shenoy HG, Horgan K, Hughes TA. Surgery induced immunosuppression. Surgeon. 2011; 9(1):38–43.
Article
13. Kleyweg RP, van der Meché FG. Treatment related fluctuations in Guillain-Barré syndrome after high-dose immunoglobulins or plasma-exchange. J Neurol Neurosurg Psychiatry. 1991; 54(11):957–60.
14. Ruts L, Drenthen J, Jacobs BC, van Doorn PA; Dutch GBS Study Group. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study. Neurology. 2010; 74(21):1680–6.
Article
Full Text Links
  • JR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr